|
|
| CAS番号. | 569348-14-7 |
| 化学名: | |
| 别名: | |
| 英語化学名: | 1-N-CBZ-NIPECOTAMIDE
|
| 英語别名: | 1-Cbz-3-piperidinecarboxamide;Benzyl 3-carbaMoylpiperidine-1-carboxylate;3-Carbamoylpiperidine-1-carboxylic acid benzyl ester;1-Piperidinecarboxylic acid, 3-(aminocarbonyl)-, phenylmethyl este;1-Piperidinecarboxylic acid, 3-(aminocarbonyl)-, phenylmethyl ester |
| CBNumber: | CB01118780 |
| 分子式: | C14H18N2O3 |
| 分子量: | 262.3 |
| MOL File: | 569348-14-7.mol |
|
|
|
|
| 1-N-CBZ-NIPECOTAMIDE
物理性質 |
|
|
1-N-CBZ-NIPECOTAMIDE
化学特性,用途語,生産方法 |
|
|
| 1-N-CBZ-NIPECOTAMIDE
上流と下流の製品情報 |
原材料
|
準備製品
|
| 1-N-CBZ-NIPECOTAMIDE
生産企業 Global( 21)Suppliers |
| 名前 | 電話番号 | ファックス番号 | 電子メール | 国籍 | 製品カタログ | 優位度 |
|
J & K SCIENTIFIC LTD.
| -- | -- | jkinfo@jkchemical.com;market3@jkchemical.com | CHINA |
96847
|
76
|
|
Shangchem Co., Ltd.
| +86-21-68182121，+86 15000169545 | +86-21-68182121 | steven@shangchem.com | CHINA |
882
|
52
|
|
Accela ChemBio Co.,Ltd.
| 021-50795510-107/109 400-066-5055 | 021-50795055 | sales@accelachem.com | CHINA |
10949
|
64
|
|
Shanghai Longsheng chemical Co.,Ltd.
| 0086-21-58099637,58099652,58099650,58099609 To 8017,8068; 13585536065 | 0086-21-33191781 | sales@shlschem.com; bin.wu@shlschem.com；xianjun.hong@shlschem.com | CHINA |
9850
|
59
|
|
skychemical Co.Ltd
| 021-20958197 20965099 | 021-20960837 | sales@skychemical.com | CHINA |
1184
|
57
|
|
Richest Group Limited
| +86 21 5017 5386/3175 7285/86/87/88/89 | +86 21 6085 3086 | info@richest-group.com | CHINA |
13964
|
57
|
|
Shanghai Nuohey Chemical Co., Ltd.
| +86 (21) 61722002,61538832,51093016,13761626812 QQ:2817342338,3265115313,934678158 | +86 (21) 51062076 | sales@nuohey.com | CHINA |
10069
|
60
|
|
Shanghai LiuShi Pharmaceutical Technology Co., Ltd.
| 021-60135539 | 021-38721356 | shlschemical@hotmail.com | CHINA |
9967
|
55
|
|
Suzhou Ryan Pharmachem Technology Co.,Ltd
| 0512-66585217 13962137180 | 0512-82177549 | sales@ryanchem.com | CHINA |
300
|
55
|
|
Bide Pharmatech Ltd.
| +86-21-61629020 | +86-21-61629029 | product@bidepharmatech.com | CHINA |
40303
|
60
|
|
|
|
|